http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Chris Adalikwu,Paul Adalikwu,William Undie 한국외국어대학교 지식출판콘텐츠원 글로벌경영연구소 2010 글로벌경영연구 = Journal of global business research Vol.22 No.2
To strategy scholars and managers, the origin of organizational capabilities is elusive. A scholar wonders “where [do] capabilities come from [and] what kinds of investment in money, time, and managerial efforts is required in building them” Ethiraj, et al. (2005, Strategic Management Journal, 26, 25-45). This study traced the trajectory of strategic asset deployment by Amgen’s top echelon to capture the origin of Amgen’s drug innovation capabilities. Sequentially, Amgen’s top echelon strategically acquired star scientists, who in turn, developed Amgen’s drug innovation capabilities. This finding is consistent with the upper-echelon and resource-based theories about the strategic roles of top managers in developing organizational capabilities. We hope, managers should learn from this insightful case.